Find a Clinical Trial
Filter
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
KPI-012-C-001
Corneal disorders
All genders
18+
Recruiting now
Department of Ophthalmology
ANHL1931
Lymphoma
All genders
2+
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology